Literature DB >> 30291434

Mitochondrial disorder mimicking rheumatoid disease.

Josef Finsterer1,2, Madleine Melichart-Kotig3, Adelheid Woehrer4.   

Abstract

OBJECTIVE: Mitochondrial disorders (MIDs) may manifest phenotypically with a plethora of clinical features, but polyarthralgia and cutaneous lesions are still infrequently reported and recognized as phenotypic manifestations of a MID. CASE REPORT: The patient is a 27-year-old Caucasian female with a history of preterm birth, symptomatic myopathy, and polyarthralgia since infancy, followed by multiple endocrinopathies including pituitary insufficiency, cardiac conduction defects, nephrolithiasis, aseptic chronic pancreatitis and sialadenitis, anemia, hyperlipidemia, and dysmorphic features. The patient reported to have profited from hydrocortisone and long-term chloroquine, but hardly from long-term immunosuppression with various immunosuppressants. The diagnosis MID was established upon the multiorgan nature of the disease, presence of core clinical features of a MID, and a muscle biopsy indicative of a mitochondrial defect. The family history was positive for mitochondrial features in the mother and grandmother from the mother's side.
CONCLUSION: Seronegative and non-destructive polyarthralgia and unexplained cutaneous features mimicking cutaneous lupus should be considered as a phenotypic feature of a multisystem MID (mitochondrial multiorgan disorder syndrome, MIMODS). Mitochondrial metabolic defects may trigger secondary immune reactions. Core clinical features of a non-specific MID with infantile onset include symptomatic myopathy, endocrine abnormalities, cardiac conduction defects, dysmorphism, hyperlipidemia, anemia, and nephrolithiasis.

Entities:  

Keywords:  Arthralgia; Mitochondrion; MtDNA; Myopathy; Neuromuscular; Pituitary insufficiency

Mesh:

Year:  2019        PMID: 30291434     DOI: 10.1007/s00393-018-0551-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  11 in total

1.  Congenital myasthenic syndrome in Japan: ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits.

Authors:  Yoshiteru Azuma; Tomohiko Nakata; Motoki Tanaka; Xin-Ming Shen; Mikako Ito; Satoshi Iwata; Tatsuya Okuno; Yoshiko Nomura; Naoki Ando; Keiko Ishigaki; Bisei Ohkawara; Akio Masuda; Jun Natsume; Seiji Kojima; Masahiro Sokabe; Kinji Ohno
Journal:  Neuromuscul Disord       Date:  2014-09-10       Impact factor: 4.296

2.  Skin manifestations of mitochondrial dysfunction: more important than previously thought.

Authors:  Sarah Jayne Boulton; Amy Bowman; Roxanna Koohgoli; Mark A Birch-Machin
Journal:  Exp Dermatol       Date:  2015-01       Impact factor: 3.960

3.  Affection of immune cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Acta Neurol Belg       Date:  2017-07-22       Impact factor: 2.396

4.  Regulated in Development and DNA Damage Response 1 Deficiency Impairs Autophagy and Mitochondrial Biogenesis in Articular Cartilage and Increases the Severity of Experimental Osteoarthritis.

Authors:  Oscar Alvarez-Garcia; Tokio Matsuzaki; Merissa Olmer; Lars Plate; Jeffery W Kelly; Martin K Lotz
Journal:  Arthritis Rheumatol       Date:  2017-06-02       Impact factor: 10.995

Review 5.  Mouse models for mitochondrial disease.

Authors:  D C Wallace
Journal:  Am J Med Genet       Date:  2001

6.  Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.

Authors:  V Mihaylova; R H Scola; B Gervini; P J Lorenzoni; C K Kay; L C Werneck; R Stucka; V Guergueltcheva; M von der Hagen; A Huebner; A Abicht; J S Müller; H Lochmüller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

Review 7.  Abnormalities of Skin and Cutaneous Appendages in Neuromuscular Disorders.

Authors:  Josef Finsterer; Salma Wakil
Journal:  Pediatr Neurol       Date:  2015-05-09       Impact factor: 3.372

8.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

9.  Mitochondrial DNA (mtDNA) haplogroups influence the progression of knee osteoarthritis. Data from the Osteoarthritis Initiative (OAI).

Authors:  Angel Soto-Hermida; Mercedes Fernández-Moreno; Natividad Oreiro; Carlos Fernández-López; Sonia Pértega; Estefania Cortés-Pereira; Ignacio Rego-Pérez; Francisco J Blanco
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

10.  Molecular characterization of congenital myasthenic syndromes in Spain.

Authors:  D Natera-de Benito; A Töpf; J J Vilchez; L González-Quereda; J Domínguez-Carral; J Díaz-Manera; C Ortez; M Bestué; P Gallano; M Dusl; A Abicht; J S Müller; J Senderek; A García-Ribes; N Muelas; T Evangelista; Y Azuma; G McMacken; A Paipa Merchan; P M Rodríguez Cruz; A Camacho; E Jiménez; M C Miranda-Herrero; A Santana-Artiles; O García-Campos; R Dominguez-Rubio; M Olivé; J Colomer; D Beeson; H Lochmüller; A Nascimento
Journal:  Neuromuscul Disord       Date:  2017-08-18       Impact factor: 4.296

View more
  2 in total

1.  Secondary manifestations of mitochondrial disorders.

Authors:  Josef Finsterer
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

Review 2.  Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease.

Authors:  Alice Lepelley; Timothy Wai; Yanick J Crow
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.